Background. Many of the therapeutic proposals for COVID-19 are already associated with adverse outcomes, such as the danger of QT interval prolongation and torsades de pointes (TdP). The objective was to ascertain the use of drugs having a chance of QT interval prolongation in 21 clinics/hospitals in Colombia from https://directivepublications.org/journal-of-vascular-medicine/